Cherfils-Vicin et al. reported that TLR8 was expressed in human lung cancer cells, and PolyU (TLR8 ligand) could upregulate B-cells lymphoma-2 (Bcl-2) and promote the survival of lung cancer cells. The gene discussed is BCL2; the disease is lung carcinoma.